A. Szilagyi

发表

Clinical variables related to small bowel obstruction: comparison of patients with and without Crohn's disease

P. gordon, C. Holcroft, A. A. Qahtani, 2012 .

Determinants of geographic patterns of diseases: interaction of lactose/lactase status and sunshine exposure.

A. Szilagyi, 2010, Medical hypotheses.

Significant Positive Correlation Between Sunshine and Lactase Nonpersistence in Europe May Implicate Both in Similarly Altering Risks for Some Diseases

I. Shrier, B. Burstein, A. Szilagyi, 2011, Nutrition and cancer.

Estimating Lactase Nonpersistence Distributions in the Multi-Ethnic Canadian Demographic: A Population-Based Study

X. Xue, A. Szilagyi, M. Fung, 2018, Journal of the Canadian Association of Gastroenterology.

Lack of effect of lactose digestion status on baseline fecal micoflora.

I. Shrier, Sunghoon Park, G. Chong, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Use of prebiotics for inflammatory bowel disease.

A. Szilagyi, 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine

N. Hilzenrat, K. Fortinsky, A. Szilagyi, 2016, Case Reports in Gastroenterology.

Lactose Intolerance, Dairy Avoidance, and Treatment Options

A. Szilagyi, Norma Ishayek, 2018, Nutrients.

Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms

A. Szilagyi, 2019, Clinical Journal of Gastroenterology.

Evaluation of a fecal immunochemistry test prior to colonoscopy for outpatients with various indications

X. Xue, A. Szilagyi, 2017, Clinical and experimental gastroenterology.

Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology

A. Szilagyi, Ismail A. Raslan, M. Alameldin, 2018, BMJ Case Reports.

Colonically Adapted Lactose Naldigesters May Bias Dietary Studies of Colorectal Cancer

A. Szilagyi, 2004, Digestive Diseases and Sciences.

Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.

X. Xue, A. Szilagyi, 2018, Medical hypotheses.

Endoscopist-Directed Propofol as an Adjunct to Standard Sedation: A Canadian Experience

A. Cohen, N. Hilzenrat, R. Battat, 2018, Journal of the Canadian Association of Gastroenterology.

Redefining lactose as a conditional prebiotic.

A. Szilagyi, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Lactose — a potential prebiotic

A. Szilagyi, 2002 .

Influence of loperamide on lactose handling and oral–caecal transit time

A. Szilagyi, R. Salomón, E. Seidman, 1996, Alimentary pharmacology & therapeutics.

Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model

B. Burstein, X. Xue, A. Szilagyi, 2014, Clinical epidemiology.

Ethanol, Thyroid Hormones and Acute Liver Injury: Is There a Relationship?

R. Resnick, A. Szilagyi, S. Lerman, 2007, Hepatology.

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort.

A. Cohen, A. Bitton, Y. Xiao, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study

S. Vermeire, M. Ferrante, U. Kopylov, 2017, Inflammatory bowel diseases.

Systematic review: the use of somatostatin or octreotide in refractory diarrhoea

I. Shrier, A. Szilagyi, 2001, Alimentary pharmacology & therapeutics.

Cholangiocarcinoma: A Decade's Experience at a Community-Based University Hospital

B. Mitmaker, A. Szilagyi, E. Lamoureux, 1990 .

Lactose intolerance and other related food sensitivities

A. Szilagyi, Catherine Walker, Mark G Thomas, 2019, Lactose.

CASE REPORT: Henoch-Schonlein Purpura Presenting with Ileal Involvement in an Adult

A. Szilagyi, C. Turbide, R. Karagozian, 2004, Digestive Diseases and Sciences.

Improved Parameters of Lactose Maldigestion Using Lactulose

A. Szilagyi, J. Rivard, K. Fokeeff, 2001, Digestive Diseases and Sciences.

Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital.

A. Gologan, A. Szilagyi, P. Galiatsatos, 2012, Gastroenterology & hepatology.

Infliximab therapy for moderately severe Crohn’s disease and ulcerative colitis: a retrospective comparison over 6 years

A. Cohen, C. Holcroft, A. Szilagyi, 2011, Clinical and experimental gastroenterology.

Possible therapeutic use of loperamide for symptoms of lactose intolerance.

A. Szilagyi, A. Torchinsky, A. Calacone, 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Failure to improve parameters of lactose maldigestion using the multiprobiotic product VSL3 in lactose maldigesters: a pilot study.

A. Cohen, A. Szilagyi, Rose Yesovitch, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Diminished Efficacy of Colonic Adaptation to Lactulose Occurs in Patients with Inflammatory Bowel Disease in Remission

I. Shrier, A. Szilagyi, J. Rivard, 2002, Digestive Diseases and Sciences.

Intrafamilial Spread of Hepatitis B: Passage Through Several Generations

I. G. Fantus, A. Szilagyi, Jacques M Chan-Thin, 1993 .

Cullen's sign: it doesn't always mean hemorrhagic pancreatitis.

M. Chung, A. Szilagyi, C. Oung, 1992, The American journal of gastroenterology.

Functional Disaccharides Lactulose, Lactitol, and Lactose

A. Szilagyi, 2009 .

Meta-analysis of Outcome of Cytomegalovirus Colitis in Immunocompetent Hosts

I. Shrier, A. Szilagyi, E. Lamoureux, 2005, Digestive diseases and sciences.

Adult lactose digestion status and effects on disease.

A. Szilagyi, 2015, Canadian journal of gastroenterology & hepatology.

Meta‐analysis: the diagnostic accuracy of lactose breath hydrogen or lactose tolerance tests for predicting the North European lactase polymorphism C/T‐13910

X. Xue, A. Szilagyi, A. Marton, 2012, Alimentary pharmacology & therapeutics.

Use of Interferon for Prevention of Hepatocellular Carcinoma in Cirrhotic Patients with Hepatitis B or Hepatitis C Virus Infection

A. Sherker, A. Szilagyi, I. Shrier, 1999, Annals of Internal Medicine.

Adaptation to Lactose in Lactase Non Persistent People: Effects on Intolerance and the Relationship between Dairy Food Consumption and Evalution of Diseases

A. Szilagyi, 2015, Nutrients.

Differential impact of lactose/lactase phenotype on colonic microflora.

I. Shrier, Sunghoon Park, G. Chong, 2010, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Hyperemesis Gravidarum and Helicobacter pylori Infection: A Systematic Review

L. Graves, A. Szilagyi, Deborah Golberg, 2007, Obstetrics and gynecology.

Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for “Gibsons' Conundrum”

A. Szilagyi, Q. M. Fung, 2012, International journal of inflammation.

Evaluation of Relationships Among National Colorectal Cancer Mortality Rates, Genetic Lactase Non-Persistence Status, and Per Capita Yearly Milk and Milk Product Consumption

I. Shrier, Christina Vinokuroff, J. Correa, 2006, Nutrition and cancer.

The Effect of Lactose Maldigestion on the Relationship Between Dairy Food Intake and Colorectal Cancer: A Systematic Review

I. Shrier, Christina Vinokuroff, J. Correa, 2006, Nutrition and cancer.

Altered colonic environment, a possible predisposition to colorectal cancer and colonic inflammatory bowel disease: rationale of dietary manipulation with emphasis on disaccharides.

A. Szilagyi, 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Adverse reactions to food constituents: allergy, intolerance, and autoimmunity.

M. Zarkadas, D. Kitts, A. Szilagyi, 1997, Canadian journal of physiology and pharmacology.

Effect of Ursodeoxycholic Acid on Granulomatous Liver Disease Due to Sarcoidosis

L. Alpert, A. Szilagyi, E. Lamoureux, 2005, Digestive Diseases and Sciences.

Global associations of national economic wealth are more robust with inflammatory bowel diseases than with obesity.

N. Sebbag, X. Xue, A. Szilagyi, 2021, Medical hypotheses.

Changing Patterns of Relationships Between Geographic Markers and IBD: Possible Intrusion of Obesity

N. Sebbag, X. Xue, A. Szilagyi, 2020, Crohn's & colitis 360.

Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

J. Galipeau, P. Ghali, Majid Abdulrahman Almadi, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Pharmacological therapy of vascular malformations of the gastrointestinal tract.

A. Szilagyi, M. Ghali, 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families

P. gordon, J. Cassoff, B. Burstein, 2013, Nutrition Journal.

Digestion, absorption, metabolism, and physiological effects of lactose

A. Szilagyi, 2019, Lactose.

Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases

X. Xue, A. Szilagyi, P. Galiatsatos, 2015, Nutrition Journal.

Acute Symptomatic Gastritis Due to Helicobacter heilmannii

L. Alpert, W. Al-Hamoudi, A. Szilagyi, 2006, Helicobacter.

Vitamin B12 Deficiency in Inflammatory Bowel Disease: Prevalence, Risk Factors, Evaluation, and Management

A. Bitton, E. Seidman, U. Kopylov, 2014, Inflammatory bowel diseases.

Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease--the McGill experience.

A. Cohen, A. Bitton, E. Seidman, 2014, Journal of Crohn's & colitis.

Impact of Lactose Containing Foods and the Genetics of Lactase on Diseases: An Analytical Review of Population Data

I. Shrier, J. Correa, A. Szilagyi, 2008, Nutrition and cancer.

An unusual cause of upper gastrointestinal bleeding.

Majid Abdulrahman Almadi, Ahmad A. Alharbi, A. Szilagyi, 2012, Gastroenterology.

Relationships between Western Non Communicable Diseases and Geographic Pattern Modifiers Based on Latitude and Lactase Distributions

A. Szilagyi, 2022, Medical Hypotheses.

Fructose Malabsorption May Be Gender Dependent and Fails to Show Compensation by Colonic Adaptation

A. Cohen, Christina Vinokuroff, X. Xue, 2007, Digestive Diseases and Sciences.

Lactose handling by women with lactose malabsorption is improved during pregnancy.

A. Szilagyi, R. Salomón, E. Seidman, 1996, Clinical and investigative medicine. Medecine clinique et experimentale.

Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.

A. Szilagyi, D. Heilpern, 2008, Reviews on recent clinical trials.

Comparison of a real-time polymerase chain reaction assay for lactase genetic polymorphism with standard indirect tests for lactose maldigestion.

N. Hilzenrat, G. Chong, X. Xue, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

There is no difference in the disease severity of gastro‐oesophageal reflux disease between patients infected and not infected with Helicobacter pylori

A. Barkun, C. Fallone, S. Mayrand, 2004, Alimentary pharmacology & therapeutics.

Inverse Dose Effect of Pretest Dietary Lactose Intake on Breath Hydrogen Results and Symptoms in Lactase Nonpersistent Subjects

A. Cohen, Christina Vinokuroff, X. Xue, 2005, Digestive Diseases and Sciences.

Complex Interactions of Obesity, Dairy Food Intake and Genetics of Lactase

A. Szilagyi, 2018 .

Hepatitis B and alcoholic liver disease.

A. Szilagyi, 1984, Gastroenterology.

Prolonged treatment duration is required for successful Helicobacter pylori eradication with proton pump inhibitor triple therapy in Canada.

A. Barkun, M. Sewitch, C. Fallone, 2013, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Clinical and histopathological variation in hepatocellular carcinoma.

L. Alpert, A. Szilagyi, 1995, American Journal of Gastroenterology.

Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis.

H. Schipper, A. Szilagyi, N. Just, 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Caco-2 cell disaccharidase activities are unaffected by gestational hormones.

E. Levy, D. Levesque, A. Szilagyi, 1996, Canadian journal of physiology and pharmacology.

High fructose intake fails to induce symptomatic adaptation but may induce intestinal carriers

B. Lee, R. Abbas, A. Szilagyi, 2010 .

Hepatocellular carcinoma: comparison of clinical features among ethnic groups in an area of low prevalence.

J. Lough, A. Szilagyi, D. Poenaru, 1991, The American journal of gastroenterology.

Dermatomyositis with Kaposi’s Sarcoma in a Patient without Human Immunodeficiency Virus-1 Infection

A. Szilagyi, H. Srolovitz, R. Billick, 1991 .

Saint-Anthony's Fire

S. Kahn, A. Szilagyi, S. Christopoulos, 2001, The Lancet.

Deadaption and readaptation with lactose, but no cross-adaptation to lactulose: a case of occult colonic bacterial adaptation.

A. Cohen, Christina Vinokuroff, A. Szilagyi, 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Review article: lactose--a potential prebiotic.

A. Szilagyi, 2002, Alimentary pharmacology & therapeutics.

Clinical Epidemiology Dovepress

B. Burstein, X. Xue, A. Szilagyi, 2022 .

Propylthiouracil for alcoholic hepatitis: potential role of the ethanol metabolic rate.

A. Szilagyi, 1982, Gastroenterology.

Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review.

J. Galipeau, P. Ghali, Majid Abdulrahman Almadi, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.